The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Wave Life Sciences Ltd. shares valued at $96,421 were sold by Moran Kyle on Apr 03 ’24. At $6.17 per share, Moran Kyle sold 15,630 shares. The insider’s holdings dropped to 33,921 shares worth approximately $0.18 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, RA CAPITAL MANAGEMENT, L.P. purchased 1,000,000 shares, netting a total of over 5,000,000 in proceeds. Following the buying of shares at $5.00 each, the insider now holds 19,202,009 shares.
Before that, GSK plc had added 3,300,000 shares to its account. In a trade valued at $16,500,000, the 10% Owner bought Wave Life Sciences Ltd. shares for $5.00 each. Upon closing the transaction, the insider’s holdings increased to 3,300,000 shares, worth approximately $75.37 million.
As published in their initiating research note from Wells Fargo on May 15, 2024, Wave Life Sciences Ltd. [WVE] has been an Overweight and the price target has been revised to $11. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid December. As of July 05, 2023, Raymond James has initiated its “an Outperform” rating for WVE. Earlier on May 24, 2023, Jefferies downgraded its rating. Their new recommendation was “a Hold” for WVE stock which previously was a “a Buy”.
Analyzing WVE Stock Performance
During the last five days, there has been a surge of approximately 23.20%. Over the course of the year, Wave Life Sciences Ltd. shares have jumped approximately 6.73%. Shares of the company reached a 52-week high of $7.67 on 03/07/24 and a 52-week low of $3.50 on 02/14/24. A 50-day SMA is recorded $5.70, while a 200-day SMA reached $5.36. Nevertheless, trading volume fell to 0.27 million shares from 0.61 million shares the previous day.
Support And Resistance Levels for Wave Life Sciences Ltd. (WVE)
According to the 24-hour chart, there is a support level at 5.24, which, if violated, would cause prices to drop to 5.15. In the upper region, resistance lies at 5.38. The next price resistance is at 5.43. RSI (Relative Strength Index) is 47.42 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.09, which suggests the price will decrease in the coming days. Percent R is at 52.23%, indicating low price movement. Stochastics%K at holding indicates that the stock is to be held.
Which companies own the most shares of Wave Life Sciences Ltd. (WVE)?
On December 15, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and resumed coverage with a $20.
